vs

Side-by-side financial comparison of NewGenIvf Group Ltd (NIVF) and Progyny, Inc. (PGNY). Click either name above to swap in a different company.

NewGenIvf Group Ltd is a specialized assisted reproductive technology (ART) service provider. It offers a full range of fertility solutions including in vitro fertilization, preimplantation genetic testing and fertility preservation, primarily serving clients across Greater China and Southeast Asia, including both local and cross-border patients seeking reproductive care.

Progyny, Inc. is a leading fertility and family building benefits provider operating primarily in the United States. It partners with employers to offer benefits including in vitro fertilization, fertility preservation, adoption assistance, and surrogacy support, serving millions of members across diverse industry segments.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NIVF
NIVF
PGNY
PGNY
Q4 25
$318.4M
Q3 25
$313.3M
Q2 25
$332.9M
Q1 25
$324.0M
Q4 24
$298.4M
Q3 24
$286.6M
Q2 24
$304.1M
Q1 24
$278.1M
Net Profit
NIVF
NIVF
PGNY
PGNY
Q4 25
$12.5M
Q3 25
$13.9M
Q2 25
$17.1M
Q1 25
$15.1M
Q4 24
$10.5M
Q3 24
$10.4M
Q2 24
$16.5M
Q1 24
$16.9M
Gross Margin
NIVF
NIVF
PGNY
PGNY
Q4 25
24.1%
Q3 25
23.2%
Q2 25
23.7%
Q1 25
23.4%
Q4 24
21.3%
Q3 24
20.7%
Q2 24
22.5%
Q1 24
22.4%
Operating Margin
NIVF
NIVF
PGNY
PGNY
Q4 25
4.8%
Q3 25
6.9%
Q2 25
7.3%
Q1 25
7.5%
Q4 24
5.3%
Q3 24
4.3%
Q2 24
6.8%
Q1 24
6.7%
Net Margin
NIVF
NIVF
PGNY
PGNY
Q4 25
3.9%
Q3 25
4.4%
Q2 25
5.1%
Q1 25
4.6%
Q4 24
3.5%
Q3 24
3.6%
Q2 24
5.4%
Q1 24
6.1%
EPS (diluted)
NIVF
NIVF
PGNY
PGNY
Q4 25
$0.14
Q3 25
$0.15
Q2 25
$0.19
Q1 25
$0.17
Q4 24
$0.12
Q3 24
$0.11
Q2 24
$0.17
Q1 24
$0.17

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons